81 results
424B5
IKT
Inhibikase Therapeutics Inc
22 May 24
Prospectus supplement for primary offering
8:55am
securities in respect of which this prospectus is being delivered, we will disclose their names and the nature of our arrangements with them
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except … Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not joint
8-K
EX-10.2
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
of the Company; and no injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction shall have been
8-K
EX-99.1
3p3ww2
30 Apr 24
Regulation FD Disclosure
8:17am
424B5
l2gbhla2b1a j2
1 Feb 24
Prospectus supplement for primary offering
4:49pm
8-K
EX-10.1
db6m 0n1cp0
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm